Twitter
-
Recent Posts
- The Mysteries of the Mind
- Have management papers ever changed practice in healthcare?
- Maternal Mortality Falling – But Still Too High
- This Week in PLoS Medicine: Pregnancy in DART trial; Health & pharmaceutical R&D
- This Week in PLoS Medicine: Co-proxamol deaths; Aid & govt spending; HIV & TB in prisons
Categories
- Access (24)
- Ask PLoS Medicine (5)
- Authors (19)
- Birthday (2)
- Collections (8)
- Conference news (24)
- General (250)
- Ghostwriting (12)
- Global Health (28)
- Global Health Systems (7)
- malERA (3)
- Maternal Newborn and Child Health (6)
- Media (24)
- Media Releases (6)
- Mental Health (8)
- MSF (24)
- Neglected Diseases (23)
- Open Access (2)
- Open Access Week 2009 (3)
- Peer review (1)
- PLoS Medicine Week by Week (90)
- PLoS Medicine's Daily Click (64)
- Podcasts (3)
- Policy (82)
- Public (62)
- Research Ethics (5)
- Reviewers (3)
- Road Traffic Crashes (2)
- Students (18)
- Videos (4)
- World Health Report 2012 (3)
Tag Archives: Ghostwriting
Ghostwriting documents now fully available on PLoS Medicine website
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, pharmaceutical industry, research ethics
11 Comments
Ghostwriting 101
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
3 Comments
What should be done to tackle ghostwriting in medical literature?
Category: Authors, Ghostwriting, Media, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
4 Comments
PLoS Medicine and the New York Times victorious in court; Public will have access to ghostwriting documents
Category: Authors, Ghostwriting, Media, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
13 Comments
Successful intervention by PLoS Medicine and New York Times in Federal court grants public access to evidence that drug company ‘ghostwrote’ medical articles about hormone therapy drug, Prempro
Category: Authors, Ghostwriting, Public
Tagged Ghostwriting, medical literature, pharmaceutical industry
2 Comments

